Tag: Nawal Ouzren

All

Latest

Sensorion, Sonova Sign Research Collaboration

Sensorion and Sonova announced that they have signed a multi-year strategic collaboration with the aim of introducing genetic analysis to the routine diagnosis of progressive hearing loss in adults, thereby opening the way for “improved care through a combination of advanced therapeutic interventions and traditional hearing aids.”

All

Latest

Sensorion and Pasteur Institute to Collaborate on Gene Therapy Products

Sensorion announced a letter of intent with Pasteur Institute in Paris to exclusively negotiate a framework agreement to obtain the exclusive licenses to develop and commercialize gene therapy product candidates for restoration, treatment, and prevention of hearing loss disorders. They will collaborate on several lead programs to correct monogenic forms of hereditary hearing loss including, among others, the Usher syndrome type 1 and otoferlin deficiency, according to the announcement.

Sensorion to Present Data at ANS Annual Meeting, April 20-22

The data being presented by Sensorion include results from a study of SENS-401 in preclinical models, designed to determine how long after hearing loss onset SENS-401 could be administered, and results from a study conducted in collaboration with the University of Connecticut (UConn Health) of a circulating blood biomarker for hearing loss.

Read More
Loading